Various imaging modalities such as mammography, MRI, and ultrasound facilitate in the screening and staging of breast cancer by identifying characteristic masses or calcifications in the breast tissue.
Breast imaging technologies are used for the early detection of breast-related disorders. These technologies are mainly used to detect breast cancer at its initial stages.
The global breast imaging technologies market is expected to reach $4,502 million by 2022 from $2,544 million in 2015, growing at a CAGR of 8.4% during the forecast period. This market is expected to witness significant growth ahead owing to the increase in incidence of breast cancer globally and rise in initiatives by healthcare organizations to raise awareness about the early detection of breast cancer.
The main drivers of the market include the need for technologically advanced products (such automated whole breast ultrasound system (AWBU)) for breast imaging and favorable reimbursement scenario. However, high cost of these imaging modalities and stringent regulatory approval processes hamper the market growth.
Request for Sample Copy@ www.bigmarketresearch.com/request-sample/893675
The breast imaging technologies market is segmented on the basis of product type and geography. Based on product type, it is bifurcated into ionizing breast imaging and non-ionizing breast imaging technologies.
Ionizing breast imaging technologies include analog mammography, full-field digital mammography, 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone beam computed tomography (CBCT), and positron emission mammography (PEM). On the other hand, non-ionizing breast imaging technologies are further divided into breast MRI, breast ultrasound, optical imaging, whole breast ultrasound, and breast thermography.
The market is analyzed based on four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.
Prominent players adopted product development (including product launches and approvals) as their key developmental strategy for expanding their product portfolio. For instance, in June 2014, GE Healthcare received FDA approval of Invenia ABUS, which is an automated breast ultrasound system used for breast cancer detection.
This system helps in detecting breast cancer in women with dense tissue when used as an adjunct with a mammogram.
For Report Enquiry@ www.bigmarketresearch.com/purchase-enquiry/893675
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics from 2014 to 2022 in the global breast imaging technologies market.
- Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities across the geographies and predict the competitive environment.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region- and country-wise breast imaging market conditions are comprehensively analyzed.
Category: Market Research Publishers and RetailersCompany about: With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency. With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market ...